Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Benitec Biopharma Inc. BNTC
$0.22
-$0 (-1.45%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
6561591.00000000
-
week52high
2.10
-
week52low
0.13
-
Revenue
73000
-
P/E TTM
0
-
Beta
1.15467100
-
EPS
-1.56000000
-
Last Dividend
0.04500000
-
Next Earnings Date
15 мая 2023 г. в 12:00
Описание компании
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 17 февр 2022 г. | |
| Ladenburg Thalmann | Neutral | Buy | 25 ноя 2020 г. |
| Ladenburg Thalmann | Neutral | Buy | 05 окт 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 23 сент 2022 г. |
| JMP Securities | Market Outperform | 18 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Francis Peter | A | 12000 | 12000 | 07 дек 2022 г. |
| BUCHI J KEVIN | A | 12000 | 12000 | 07 дек 2022 г. |
| Smith Edward F | A | 12000 | 12000 | 07 дек 2022 г. |
| Oliveira Steven Michael | A | 1000000 | 10553 | 09 дек 2021 г. |
| Francis Peter | A | 12000 | 12000 | 08 дек 2021 г. |
| Smith Edward F | A | 12000 | 12000 | 08 дек 2021 г. |
| BUCHI J KEVIN | A | 12000 | 12000 | 08 дек 2021 г. |
| Oliveira Steven Michael | A | 989447 | 37947 | 29 ноя 2021 г. |
| Oliveira Steven Michael | A | 951500 | 40500 | 03 мая 2021 г. |
| Oliveira Steven Michael | A | 911000 | 120000 | 30 апр 2021 г. |
Новостная лента
Benitec Biopharma to Present at the OPMD International Conference
GlobeNewsWire
08 мая 2023 г. в 08:05
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that Jerel A.